Table 3.
Univariate and multivariate analyses of biochemical progression
| Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|
|
Parameter |
Hz |
95% CI |
p-value |
Hz |
95% CI |
p-value |
| Age |
0.93 |
0.90-0.97 |
0.001* |
0.93 |
0.88-0.99 |
0.017* |
| Performance status |
0.57 |
0.14-2.32 |
0.432 |
0.40 |
0.05-2.93 |
0.371 |
| Comorbidity |
1.02 |
0.66-1.58 |
0.931 |
1.03 |
0.56-1.82 |
0.928 |
| Smoking |
1.15 |
0.71-1.88 |
0.574 |
1.31 |
0.73-2.35 |
0.361 |
| T-stage (≥T2c vs ≤ T2b) |
0.71 |
0.44-1-16 |
0.170 |
0.58 |
0.29-1.17 |
0.128 |
| PPB# |
1.02 |
1.01-1.03 |
0.001* |
1.01 |
1.00-1.02 |
0.038* |
| Gleason score |
1.29 |
1.05-1.58 |
0.014* |
1.04 |
0.80-1.39 |
0.759 |
| PSA |
1.00 |
1.00-1.01 |
0.555 |
1.00 |
0.99-1.01 |
0.433 |
| 3DCRT vs IG-IMRT |
1.24 |
0.77-2.00 |
0.386 |
0.78 |
0.37-1.57 |
0.505 |
| Adjuvant ADT | 0.59 | 0.28-1.24 | 0.163 | 0.89 | 0.31-2.56 | 0.830 |
*Statistically significant.
#Percentage positive biopsies.